Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

4.01
Delayed Data
As of 1:52pm ET
 +0.005 / +0.12%
Today’s Change
2.96
Today|||52-Week Range
9.32
-40.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues1.1M2.4M29.5M5.2M
 
 
 
 
 
Depreciation And Amortization513.0K605.0K593.0K866.0K
 
 
 
 
 
 
Operating ExpensesGross Income--1.8M28.9M--
 
 
 
General Expenses19.9M31.5M35.6M42.0M
 
 
 
 
 
Research And Development13.6M24.9M26.3M24.5M
 
 
 
 
 
Total Operating Expenses20.4M32.1M36.2M42.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.4M-29.7M-6.7M-37.6M
 
 
 
 
 
Extraordinary Credit0.000.000.007.6M
 
 
Extraordinary Charge0.000.00-15.3M0.00
 
 
Interest Expense On Debt2.3M3.7M1.5M2.6M
 
 
 
 
 
Other Expenses1.5M0.0032.0K-651.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.1M-33.4M-23.4M-33.4M
 
 
 
 
 
Net Income-20.1M-33.4M-23.4M-33.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS17.3M22.1M39.7M43.4M
 
 
 
 
 
Shares To Calculate EPS Diluted17.3M22.1M39.7M44.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.16-$1.51-$0.59-$0.91
 
 
 
 
 
EPS Diluted-$1.16-$1.51-$0.59-$0.91